CollPlant Biotechnologies (FRA:CPT) Total Operating Expense : €15.46 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Total Operating Expense?

CollPlant Biotechnologies's Total Operating Expense for the three months ended in Sep. 2024 was €3.85 Mil. CollPlant Biotechnologies's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was €15.46 Mil.

CollPlant Biotechnologies Total Operating Expense Historical Data

The historical data trend for CollPlant Biotechnologies's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Total Operating Expense Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Operating Expense

Get a 7-Day Free Trial

7.26

7.18

12.01

16.05

15.11

CollPlant Biotechnologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Operating Expense	Get a 7-Day Free Trial															4.09	4.21	3.57	3.83	3.85

CollPlant Biotechnologies Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.46 Mil.

CollPlant Biotechnologies Total Operating Expense Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (FRA:CPT) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

CLGN:USA

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.